1. Baving, G., Ulmer, W.T.: Die Dosis-Wirkungs-Relation von peroral verabreichtem Orciprenalin bei obstruktiven Atemwegserkrankungen. Arzneim. Forsch. 20, 1083–1088 (1970)
2. Bennett, P., Blackwell, E., Davies, D.S.: Metabolism of drugs by intestinal mucosa - effect of salicylamide on bio-availability of oral isoprenaline in dogs. Abstracts VI. International Congress of Pharmacology, Helsinki, 1975, p. 583
3. Bergman, J., Persson, H., Wetterlin, K.: Two new groups of selective stimulants of adrenergic beta-receptors. Experientia 25, 899–901 (1969)
4. Blackwell, E.W., Conolly, M.E., Davies, D.S., Dollery, C.T.: The fate of isoprenaline administered by pressurized aerosols. Br. J. Pharmacol. 39, 194P–195P (1970)
5. Bogner, R.L., Walsh, J.M.: Sustained-release principle in human subjects utilizing radioactive techniques. J. Pharmac. Sci. 53, 617–620 (1964)